本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

0.4400
-0.0457-9.41%
盘后:0.46480.0248+5.64%19:53 EDT
成交量:19.94万
成交额:8.99万
市值:278.57万
市盈率:-0.02
高:0.4899
开:0.4887
低:0.4250
收:0.4857
52周最高:47.50
52周最低:0.4250
股本:633.11万
流通股本:125.01万
量比:0.64
换手率:15.95%
股息:- -
股息率:- -
每股收益(TTM):-17.6157
每股收益(LYR):-371.2241
净资产收益率:-161.86%
总资产收益率:-70.14%
市净率:0.30
市盈率(LYR):0.00

数据加载中...

2025/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/02

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/12

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/06

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/09/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K/A - Current report: [Amend]